Screening and treatment for sexually transmitted infections in pregnancy

American Family Physician

Volumn 76, Issue 2, 2007, Pages 265-270

  Majeroni, Barbara A ^a,b   Ukkadam, Sreelatha ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; ANTIRETROVIRUS AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFIXIME; CEFTRIAXONE; ERYTHROMYCIN; HEPATITIS B SURFACE ANTIGEN; METRONIDAZOLE; PENICILLIN G; PROBENECID; SPECTINOMYCIN; TINIDAZOLE; TRICHLOROACETIC ACID; VALACICLOVIR; ZIDOVUDINE;

CHLAMYDIA; CHLAMYDIASIS; DISEASE CONTROL; FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL SYMPTOM; GENITAL HERPES; GONORRHEA; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PREVALENCE; REVIEW; RISK; SCREENING; SEROLOGY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; THIRD TRIMESTER PREGNANCY; TRICHOMONIASIS; VAGINITIS; VIRUS INFECTION; VIRUS SHEDDING; VIRUS TRANSMISSION; WART VIRUS;

ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; MASS SCREENING; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 34547180870     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Workowski KA, Berman SM, for the Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006 [Published correction appears in MMWR Recomm Rep 2006;55:997]. MMWR Recomm Rep 2006;55(RR-11):1-94. Accessed March 8, 2007, at: http://www.cdc.gov/mmwr/PDF/rr/ rr5511.pdf.
2. Andrews WW, Klebanoff MA, Thom EA, Hauth JC, Carey JC, Meis PJ, et al., for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Midpregnancy genitourinary tract infection with Chlamydia trachomatis: association with subsequent preterm delivery in women with bacterial vaginosis and Trichomonas vaginalis. Am J obstet Gynecol 2006;194:493-500.
3. olshen E, Shrier LA. Diagnostic tests for chlamydial and gonorrheal infections. Semin Pediatr Infect Dis 2005;16:192-8.
4. Brocklehurst P, Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev 1998;(4):000054.
5. Adair CD, Gunter M, Stovall TG, McElroy G, Veille JC, Ernest JM. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. obstet Gynecol 1998;91:165-8.
6. Brocklehurst P. Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev 2002;(2):CD000098.
7. Cook RL, Hutchison SL, ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhea. Ann Intern Med 2005;142:914-25.
8. Ramus RM, Sheffield JS, Mayfield JA, Wendel GD Jr. A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy. Am J obstet Gynecol 2001;185:629-32.
9. Chen KT, Segu M, Lumey LH, Kuhn L, Carter RJ, Bulterys M, et al., for the New York City Perinatal AIDS Collaborative Transmission Study (PACTS) Group. Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus. obstet Gynecol 2005;106:1341-8.
10. Sheffeld JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. obstet Gynecol 2003;102:1396-403.
11. Watts DH, Brown ZA, Money D, Selke S, Huang ML, Sacks SL, et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J obstet Gynecol 2003;188:836-43.
12. Andrews WW, Kimberlin DF, Whitley R, Cliver S, Ramsey PS, Deeter R. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J obstet Gynecol 2006;194:774-81.
13. Little SE, Caughey AB. Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis. Am J obstet Gynecol 2005;193(3 pt 2):1274-9.
14. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. U.S. Department of Health and Human Services, october 12, 2006. Accessed March 8, 2007, at: http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf.
15. U.S. Preventive Services Task Force. Screening for HIV: recommendation statement. Ann Intern Med 2005;143:32-7.
16. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al., for the Women and Infants' Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29:484-94.
17. Read JS, Newell MK. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev 2005;(4):CD005479.
18. Apea-Kubi KA, Yamaguchi S, Sakyi B, Kishimoto T, ofori-Adjei D, Hagiwara T. Neisseria gonorrhea, Chlamydia trachomatis, and Treponema pallidum infection in antenatal and gynecological patients at Korle-Bu Teaching Hospital, Ghana. Jpn J Infect Dis 2004;57:253-6.
19. Wendel GD Jr, Sheffield JS, Hollier LM, Hill JB, Ramsey PS, Sanchez PJ. Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis 2002;35(suppl 2):S200-9.
20. Walker GJ. Antibiotics for syphilis diagnosed during pregnancy. Cochrane Database Syst Rev 2001;(3):CD001143.
21. Riggs MA, Klebanoff MA. Treatment of vaginal infections to prevent preterm birth: a meta-analysis. Clin obstet Gynecol 2004;47:796-807.
22. Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, et al., for the National Institute of Child Health and Human Development Network Maternal-Fetal Medicine Units. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93.
23. Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriquez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997;44:179-82.
24. Gulmezoglu AM. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev 2002;(3):CD000220.
25. okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. obstet Gynecol 2005;105:857-68.